Skip to content
TrialScanner

NCT07897721

A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors

Phase 1Not yet recruitingPFELead

Registry record

Lead sponsor
Pfizer
Conditions
Advanced Breast Cancer; Advanced or Metastatic Breast Cancer; Metastatic Breast Cancer (HR+/ HER2-); Metastatic Colorectal Adenocarcinoma
Primary completion
Mar 22, 2030Sponsor estimate
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.

Open NCT07897721 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT07897721: A Study to Learn About the... | TrialScanner